Long-term treatment with bromocriptine inhibits endometrial adenocarcinoma development in rats

Journal of Reproduction and Development

Volumn 55, Issue 2, 2009, Pages 105-109

  Yoshida, Midori ^a   Watanabe, Gen ^b   Suzuki, Tomo ^c   Inoue, Kaoru ^a   Takahashi, Miwa ^a   Maekawa, Akihiko ^d   Taya, Kazuyoshi ^b   Nishikawa, Akiyoshi ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^c YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

^d NATIONAL INSTITUTE OF TECHNOLOGY AND EVALUATION   (Japan)

Author keywords

Bromocripchne; Long term treatment; Prolactin blockade; Rat; Uteirne carcinogenesis

Indexed keywords

BROMOCRIPTINE; CARCINOGEN; DRUG DERIVATIVE; ENNG; ESTRADIOL; FOLLITROPIN; HORMONE ANTAGONIST; INHIBIN; LUTEINIZING HORMONE; METHYLNITRONITROSOGUANIDINE; PROGESTERONE; PROLACTIN;

ADENOCARCINOMA; ANIMAL; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; CYTOCHEMISTRY; DRUG ANTAGONISM; ENDOMETRIUM TUMOR; FEMALE; PATHOLOGY; RAT;

ADENOCARCINOMA; ANIMALS; BROMOCRIPTINE; CARCINOGENS; ENDOMETRIAL NEOPLASMS; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HISTOCYTOCHEMISTRY; HORMONE ANTAGONISTS; INHIBINS; LUTEINIZING HORMONE; METHYLNITRONITROSOGUANIDINE; PROGESTERONE; PROLACTIN; RATS;

ANIMALIA; RATTUS;

EID: 66949143338     PISSN: 09168818     EISSN: 13484400     Source Type: Journal    
DOI: 10.1262/jrd.20026     Document Type: Article

References (39)

1. Sherman ME. Theories of endometrial carcinogenesis: A multidisciplinary approach. Mod Pathol 2000; 13: 295-308.
2. Maekawa A, Takahashi M, Ando J, Yoshida M. Uterine carcinogenesis by chemicals/hormones in rodents. J Toxicol Pathol 1999; 12: 1-11.
3. Nagaoka T, Onodera H, Matsushima Y, Todate A, Shibutani M, Ogasawara H, Maekawa A. Spontaneous uterine adenocarcinomas in aged rats and their relation to endocrine imbalance. J Cancer Res Clin Oncol 1990; 116: 623-628.
4. Yoshida M, Maekawa A. Uterine carcinogenesis based on estrogen or metabolite driven pathways in the Donryu rat. In: Tanaka T, Tsuda H (eds.), Carcinogenesis and Modification of Carcinogenesis. Research Signpost Kerala, India, 2005; 135-151.
5. Imai M, Jobo T, Sato R, Kawaguchi M, Kuramoto H. Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations. Eur J Gynaecol Oncol 2001; 22: 217-220.
6. Martin-Hirsch PL, Larvis G, Kitchener H, Lilford R. Progestagens for endometrial cancer. Cochrane Database System Review 2000; CD001040.
7. Susumu N, Aoki D, Suzuki N, Nozawa S. Hormonal therapy for endoemetrial adenocarcinoma. Gan To Kagaku Ryoho 2001; 28: 934-945 (In Japanese).
8. Sakurai T, Tamura K, Kogo H. Vascular endothelial growth factor increases messenger RNAs encoding cyclooxygenase-II and membrane-associated prostaglandin E synthase in rat luteal cells. J Endocrinol 2004; 183: 527-533.
9. Yadav VK, Lakshmi G, Medhamurthy R. Prostaglandin F2α-mediated activation of apoptosis signaling cascades in the corpus luteum during apoptosis. J Biol Chem 2005; 280: 10357-10367.
10. Sleer LS, Taylor CC. Platelet-derived factors and receptors in the rat corpus luteum: Localization and identification of an effect on luteogenesis. Biol Reprod 2007; 76: 391-400.
11. Malven PV. Luteotrophic and luteolytic responses to prolactin in hypophysectomized rats. Endocrinology 1969; 84: 1224-1229.
12. Taya K, Greenwald GS. In vivo and in vitro ovarian steroidogenesis in the long term hypophysectomized rat. Endocrinology 1982; 110: 390-397.
13. Rothchild I. The regulation of the mammalian corpus luteum. Recent Prog Horm Res 1981; 37: 183-298.
14. Wuttke W, Meites J. Luteolytic role of prolactin during the estrous cycle of the rat. Proc Soc Exp Biol Med 1971; 137: 988-991.
15. Bowen JM, Keyes PL. The proestrus prolactin surge is not the sole initiator of regressive changes in corpus luteum, of normally cycling rats. Biol Reprod 1999; 61: 1208-1215.
16. Gaytán F, Bellido C, Morales C, Sánchez-Criado JE. Luteolytic effect of prolactin is dependent on the degree of differentiation of luteal cell in the rat. Biol Reprod 2001; 65: 433-441.
17. Smith MS, Freeman ME, Neill JD. The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. Endocrinology 1975; 96: 219-226.
18. Bowen JM, Keyes PL, Warren JS, Townson DH. Prolactin-induced regression of the rat corpus luteum: expression of monocyte chemoattractant protein-1 and invasion of macrophages. Biol Reprod 1996; 54: 1120-1127 (Published erratum appeared in Biol Reprod 1996; 55: 224).
19. Nagano M, Kelly PA. Tissue distribution and regulation of rat prolactin receptor gene expression. J Biol Chem 1994; 269: 13337-13345.
20. Gunin AG, Emelianov V, Tolmachev AS, Tolmacheva A. Effect of prolactin and dopaminergic drugs on uterine response to chronic estrogen exposure. J Endocrinol 2002; 172: 61-69.
21. Mori T, Singtripop T, Kawashima S. Animal model of uterine adenomysosis: is prolactin a potent inducer of adenomyosis in mice? Am J Obstet Gynecol 1991; 165: 232-234.
22. Yamashita M, Matsuda M, Mori T. Increased expression of prolactin receptor mRNA in adenomyotic uterus in mice. Life Sci 1997; 60: 1437-1446.
23. Forsberg JG, Breistein LS. Prolactin and 3-methylcholanthrene induced cervical carcinoma. Effect of bromocriptine. Acta Pathol Micobiol Scand [A] 1979; 87A: 151-156.
24. Witcher JA, Freeman ME. The proestrus surge of prolactin enhances sexual receptivity in the rat. Biol Reprod 1985; 32: 834-839.
25. Ando-Lu J, Takahashi M, Imai S, Ishihara R, Kitamura T, Iijima T, Takano S, Nishiyama K, Suzuki K, Maekawa A. High-yield induction of endometrial adenocarcinomas in Donryu rats by a single intra-uterine administration of N-ethyl-N'-nitro-Nnitrosoguanidine. Jpn J Cancer Res 1994; 85: 789-793.
26. Yoshida M, Watanabe G, Shirota M, Maekawa A, Taya K. Reduction of primordial follicles caused by maternal treatment with busulfan promotes endometrial adenocarcinoma development in Donryu rats. J Reprod Dev 2005; 51: 707-714. 2005.
27. Nagaoka T, Takeuchi M, Onodera H, Matsushima Y, Ando-Lu J, Maekawa A. Sequential observation of spontaneous endometrial adenocarcinoma development in Donryu rats. Toxicol Pathol 1994; 22: 261-269.
28. Taya K, Watanabe G, Sasamoto S. Radioimmunoassay for progesterone, testosterone and estradiol-17β using 125I-iodohistamine radioligands. Jpn J Anim Reprod 1985; 31: 186-197 (In Japanese).
29. Taya K, Mizokawa T, Matsui T, Sasamoto S. Induction of superovulation in prepubertal female rats by anterior pituitary transplants. J Reprod Fertil 1983; 69: 265-270 (In Japanese).
30. Hamada T, Watanabe G, Kokuho T, Taya K, Sasamoto S, Hasegawa Y, Miyamoto K, Igarashi M. Radioimmunoassay of inhibin in various mammals. J Endocrinol 1989; 122: 697-704.
31. Katsuda S, Yoshida M, Kuroda H, Ando J, Takanashi M, Kurokawa Y, Watanabe G, Taya K, Makeawa A. Uterine adenocarcinoma in N-ethyl-N'-nitro-N-nitrosoguanidine-treated rats with high-dose exposure to p-tert-octylphenol during adulthood. Jpn J Cancer Res (Cancer Science) 2002; 93: 117-124.
32. Katsuda S, Yoshida M, Saarinen N, Smeds A, Nakae D, Santti R, Maekawa A. Chemopreventive effects of hydroxymatairesinol on uterine carcinogenesis in Donryu rats. Exp Biol Med 2004: 229: 417-424.
33. Nishiyama K, Ando-Lu J, Nishimura S, Takahashi M, Yoshida M, Sasahara K, Miyajima K, Maekawa A. Initiating and promoting effects of concurrent oral administration of ethylene thiourea and sodium nitrite on uterine endometrial adenocarcinoma development in Donryu rats. In Vivo 1998; 12: 363-368.
34. Dong J, Tsai-Morris CH, Defau ML. A novel estradiol/estrogen receptor α-dependent transcriptional mechanism controls expression of the human prolactin receptor. J Biol Chem 2006; 27: 18825-18836.
35. rd ed., Missouri: Elsevier; 2006: 1703-1726.
36. Horiguchi K, Fukuta S, Yoshida M, Kosugi T, Naito J, Ishida M, Harigaya T. Estrogen regulates the serum level of phosphorylated prolactin in mice. J Reprod Dev 2007; 53: 915-922.
37. Gunin AG, Emelianov V, Tolmachev AS, Tolmacheva A. Effect of prolactin and dopaminergic drugs on uterine response to chronic estrogen exposure. J Endocrinol 2002; 172: 61-69.
38. Alison RH, Capen CC, Prentice DE. Neoplastic lesions of questionable significance to humans. Toxicol Pathol 1994; 22: 179-186.
39. Knobil E. Patterns of hypophysiotropic signals and gonadotropin secretion in the rhesus monkey. Biol Reprod 1981; 24: 44-49.